COMMUNIQUÉS West-GlobeNewswire
-
Teladoc Health Reports Second Quarter 2026 Results
29/07/2026 -
Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)
29/07/2026 -
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
29/07/2026 -
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026 -
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
29/07/2026 -
VitalHub Announces Q2 2026 Conference Call Date
29/07/2026 -
Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
29/07/2026 -
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
29/07/2026 -
First-half 2026 results
29/07/2026 -
EssilorLuxottica: Publication of the 2026 Interim Financial Report
29/07/2026 -
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026 -
SOUND Behavioral Health Launches Corporate Community Partner Program During 60th Anniversary Year
29/07/2026 -
Résultats semestriels 2026
29/07/2026 -
As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.
29/07/2026 -
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026 -
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026 -
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
29/07/2026 -
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026 -
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
Pages